Partnership aims to generate benchtop system for clinical and drug discovery applications. Veridex is teaming up with the Massachusetts General Hospital (MGH) to develop the next-generation of its ...
Raritan, NJ (January 3, 2011) - Veridex, LLC (Veridex) today announced a collaboration with Massachusetts General Hospital to develop and commercialize a next-generation circulating tumor cell (CTC) ...
NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.
A new collaboration between Massachusetts General Hospital (MGH; Boston) and Veridex (Raritan, New Jersey), a Johnson & Johnson (J&J; New Brunswick, New Jersey) company, has been initiated to develop ...
Immunicon also filed for bankruptcy. Veridex is paying $31 million in cash for substantially all assets of Immunicon, which filed for bankruptcy. The transaction is subject to the approval by the ...
Veridex, a Johnson & Johnson company, is getting together with Massachusetts General Hospital to develop a blood test so sensitive that it can "spot a single cancer cell lurking among a billion ...
WARREN, N.J., Dec. 15, 2006 – Veridex, a Johnson & Johnson company, today announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for the CellSearch™ System to be ...
HUNTINGDON VALLEY, Pa. -- Immunicon Corporation announced today that it and its wholly-owned subsidiaries filed voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code in ...
Topoisomerase II-alpha (TOP2A) gene co-amplification does not predict response to therapy and survival in Her-2 neu positive metastatic breast cancer No significant financial relationships to disclose ...
BOSTON – A blood test so sensitive that it can spot a single cancer cell lurking among a billion healthy ones is moving one step closer to being available at your doctor's office. Boston scientists ...
HUNTINGDON VALLEY, Pa.--(BUSINESS WIRE)--Immunicon Corporation (OTC BB:IMMC.OB) announced today that it and its wholly-owned subsidiaries filed voluntary petitions for relief under Chapter 11 of the ...